Adam Peeler
Investor Relations Kontakt bei ADVANZ PHARMA CORP. LIMITED
Profil
Adam Peeler is currently the Head-Investor Relations at Eupraxia Pharmaceuticals, Inc. and the Investor Relations Contact at Advanz Pharma Corp.
Ltd.
Previously, he worked as the Manager-Investor & Public Relations at Medicure, Inc. and as the VP-Practice Lead, Healthcare & Cleantech Group at TMX Equicom, Inc. from 2008 to 2015.
Aktive Positionen von Adam Peeler
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Investor Relations Kontakt | 01.11.2015 |
| EUPRAXIA PHARMACEUTICALS INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Adam Peeler
| Unternehmen | Position | Ende |
|---|---|---|
TMX Equicom, Inc.
 TMX Equicom, Inc. Miscellaneous Commercial ServicesCommercial Services Part of TMX Group Ltd., TMX Equicom, Inc. is a Canadian company that provides investor relations services. The company is based in Toronto, Canada. | Corporate Officer/Principal | 01.11.2015 |
| MEDICURE INC. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEDICURE INC. | Health Technology |
| EUPRAXIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
TMX Equicom, Inc.
TMX Equicom, Inc. Miscellaneous Commercial ServicesCommercial Services Part of TMX Group Ltd., TMX Equicom, Inc. is a Canadian company that provides investor relations services. The company is based in Toronto, Canada. | Commercial Services |